Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Pharmacoepidemiology and Drug Safety|May 23, 2006
No association between inhaled corticosteroids and whole body DXA in postmenopausal womenSölve Elmståhl, Henrik Ekström, Olof Johnell, et al.
Endocrine Connections|March 10, 2019
Estradiol matrix patches for pubertal induction: stability of cut pieces at different temperaturesCarina Ankarberg-Lindgren, Aneta Gawlik, Berit Kriström, et al.
Hormone Research in Paediatrics|September 17, 2011
Does growth hormone treatment influence pubertal development in short children?Anna-Karin Albin, Carina Ankarberg-Lindgren, Torsten Tuvemo, et al.
Frontiers in Endocrinology|January 10, 2019
Hyperestrogenism Affects Adult Height Outcome in Growth Hormone Treated Boys With Silver-Russell SyndromeKjersti Kvernebo-Sunnergren, Carina Ankarberg-Lindgren, Karin Åkesson, et al.
Diabetes Research and Clinical Practice|September 27, 2012
The glucokinase activator AZD6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and foodHans Ericsson, Folke Sjöberg, Maria Heijer, et al.
Hormone Research in Paediatrics|March 25, 2016
First Morning Voided Urinary Gonadotropin Measurements as an Alternative to the GnRH TestAnd Demir, Raimo Voutilainen, Ulf-Håkan Stenman, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2003
Is there an association between inhaled corticosteroids and bone density in postmenopausal women?Sölve Elmståhl, Henrik Ekström, Herbert Galvard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 2006
Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD studyJenny M Kindblom, Mattias Lorentzon, Ensio Norjavaara, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy malesEnsio Norjavaara, Hans Ericsson, Folke Sjöberg, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2012
Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clampHans Ericsson, Daniel Röshammar, Maria Wollbratt, et al.
Pageof 7